HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries

This Week in 340B: April 28 – May 4, 2026

Posted In 340B

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Child Sites; Other

  • In a case against HRSA challenging its certification of a group of entities as 340B-eligible, amicus filed a motion for leave to file an amicus brief in opposition to the plaintiffs’ motion for summary judgment.
  • In a case brought by a drug manufacturer challenging a Missouri state law governing contract pharmacy arrangements, the plaintiff filed a notice of appeal.
  • In four cases brought by drug manufacturers challenging a Utah state law governing contract pharmacy arrangements, the government filed a motion to dismiss.
  • In a case brought by a trade association of drug manufacturers challenging an Oregon state law governing contract pharmacy arrangements, the plaintiff filed a response in opposition to defendant’s cross-motion for summary judgement and a reply in support of its own motion.
  • In a case brought by a drug manufacturer challenging an Oregon state law governing contract pharmacy arrangements, the plaintiff filed a response in opposition to defendant’s cross-motion for summary judgement and a reply in support of its own motion.
  • In a case against the government filed by a group of 340B covered entities seeking relief from the government’s change in its policy on child sites, the government filed a notice of appeal.

 

Emily Jane Cook
Emily Cook is a practice area leader for McDermott's Healthcare Regulatory & Compliance practice. She is a national authority on the 340B drug pricing program, and also helps clients navigate the full suite of federal and state regulations that are essential to healthcare operations. Learn more about Emily's practice here.


Reuben Bank
Reuben Bank provides regulatory and transactional counseling on all aspects of state and federal healthcare laws impacting hospitals and healthcare systems.Learn more about Reuben's practice here.


Abygail Hoey
Abygail Hoey is a member of the Health & Life Sciences Practice Group, where she focuses her practice on healthcare transactions, as well as regulatory and compliance matters. Learn more about Abygail's practice: https://www.mwe.com/people/abygail-hoey/


Deepika Raj
Deepika Raj advises a broad range of healthcare industry clients on regulatory, compliance and transactional matters. She offers multifaceted advice on state and federal fraud and abuse statutes, licensure rules, cannabis laws and due diligence matters. Learn more about Deepika's practice here.


Kelsey Reinhardt
Kelsey R. Reinhardt focuses her practice on regulatory and transactional matters affecting a wide range of clients across the healthcare industry. Learn more about Kelsey's practice here.


Nadine Tejadilla
Nadine Tejadilla focuses her practice on transactional and regulatory matters in the health and life sciences industry. While in law school, Nadine served as a legal intern at a national nonprofit civil rights organization.Learn more about Nadine's practice here.

STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm